Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19

Overview of attention for article published in Molecular Medicine, December 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 46 Mendeley

Summary X

So far, Altmetric has seen 11 X posts from 6 X users, with an upper bound of 6,254 followers.

Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19 https://t.co/GouCvJuq01

26 Nov 2022

Reply Repost Favourite

@sohalv @MPaiMD What tests are available for testing for glycocalyx damage affecting cerebral blood flow after COVID-19? (eg. syndecan-1, EndoPAT) https://t.co/3EradZ2KJc "COVID-19 patients with high levels of Syndecan-1 develop more serious endothelial

29 Mar 2022

Reply Repost Favourite

@DeansKevin @angryhacademic There are glycocalyx breakdown products (eg. syndecan-1, chondroitin sulfate, dermatan sulfate, serum hyaluronic acid, and heparan sulfate) that can be measured. Different molecular weights of these when broken down further hav

26 Mar 2022

Reply Repost Favourite

https://t.co/4twmb0wwmB

22 Mar 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.